Literature DB >> 22291078

Chemotherapy drug shortages in the United States: genesis and potential solutions.

Michael P Link, Karen Hagerty, Hagop M Kantarjian.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22291078     DOI： 10.1200/JCO.2011.41.0936

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  16 in total

1.  Drug shortages pose problems for p&t committees in accountable care organizations.

Authors:  James T O'Donnell; F Randy Vogenberg
Journal:  P T       Date:  2013-07

2.  What goes around comes around? Wernicke encephalopathy and the nationwide shortage of intravenous multivitamins revisited.

Authors:  Ross Perko; Julie H Harreld; Kathleen J Helton; Noah D Sabin; Cyrine E Haidar; Karen D Wright
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

3.  Chemotherapy drug shortages in pediatric oncology: a consensus statement.

Authors:  Matthew Decamp; Steven Joffe; Conrad V Fernandez; Ruth R Faden; Yoram Unguru
Journal:  Pediatrics       Date:  2014-02-02       Impact factor: 7.124

4.  Ethical considerations for the clinical oncologist in an era of oncology drug shortages.

Authors:  Reshma Jagsi; Rebecca Spence; W Kimryn Rathmell; Angela Bradbury; Jeffrey Peppercorn; Stephen Grubbs; Beverly Moy
Journal:  Oncologist       Date:  2014-01-21

5.  An audit of drug shortages in a community pharmacy practice.

Authors:  E M Costelloe; M Guinane; F Nugent; O Halley; C Parsons
Journal:  Ir J Med Sci       Date:  2014-05-25       Impact factor: 1.568

6.  Ethical issues for control-arm patients after revelation of benefits of experimental therapy: a framework modeled in neuroblastoma.

Authors:  Yoram Unguru; Steven Joffe; Conrad V Fernandez; Alice L Yu
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

7.  The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology Group.

Authors:  Elizabeth G Salazar; M Brooke Bernhardt; Yimei Li; Richard Aplenc; Peter C Adamson
Journal:  Pediatr Blood Cancer       Date:  2015-02-19       Impact factor: 3.167

8.  Oncologists' experiences with drug shortages.

Authors:  Kenneth L Kehl; Stacy W Gray; Benjamin Kim; Katherine L Kahn; David Haggstrom; Maryse Roudier; Nancy L Keating
Journal:  J Oncol Pract       Date:  2014-12-30       Impact factor: 3.840

9.  Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.

Authors:  Diane St Germain; Andrea M Denicoff; Eileen P Dimond; Angela Carrigan; Rebecca A Enos; Maria M Gonzalez; Kathy Wilkinson; Michelle A Mathiason; Brenda Duggan; Shaun Einolf; Worta McCaskill-Stevens; Donna M Bryant; Michael A Thompson; Stephen S Grubbs; Ronald S Go
Journal:  J Oncol Pract       Date:  2014-01-14       Impact factor: 3.840

10.  Neglected infectious diseases: are push and pull incentive mechanisms suitable for promoting drug development research?

Authors:  Frank Mueller-Langer
Journal:  Health Econ Policy Law       Date:  2013-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.